The enzyme drug L-Asparaginase represents a cornerstone in acute lymphoblastic leukemia (ALL) treatment since it exploits cancer dependency on asparagine to counteract ALL progression [280,281]. Here, ASPG is linked to acute lymphoblastic leukemia.